End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
65.9 TWD | +2.97% | -1.79% | -8.60% |
Mar. 04 | Episil Technologies Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Feb. 27 | Episil Technologies Inc. announced a financing transaction | CI |
Summary
- From a short-term investment perspective, the company presents a deteriorated fundamental configuration.
Strengths
- Its core activity has a significant growth potential and sales are expected to surge, according to Standard & Poor's' forecast. Indeed, those may increase by -100% by 2026.
- The company's profit outlook over the next few years is a strong asset.
- The company is in a robust financial situation considering its net cash and margin position.
- The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
Weaknesses
- The company's valuation in terms of earnings multiples is rather high. Indeed, the firm is getting paid 53.58 times its estimated earnings per share for the ongoing year.
- In relation to the value of its tangible assets, the company's valuation appears relatively high.
- The company is not the most generous with respect to shareholders' compensation.
- For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
- For the last four months, EPS estimates made by Standard & Poor's analysts have been revised downwards.
- The average price target of analysts who are interested in the stock has been significantly revised downwards over the last four months.
- Over the past twelve months, analysts' consensus has been significantly revised downwards.
- The group usually releases earnings worse than estimated.
Ratings chart - Surperformance
Sector: Semiconductors
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-8.60% | 676M | - | ||
+7.88% | 53.69B | B- | ||
-17.99% | 14.79B | B | ||
+13.73% | 11.02B | B+ | ||
+7.95% | 8.92B | B | ||
+21.86% | 8.7B | B- | ||
+41.91% | 8.31B | D+ | ||
-10.55% | 8.12B | B- | ||
-11.91% | 6.93B | C- | ||
-12.27% | 6.92B | B |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- 3707 Stock
- Ratings Episil Technologies Inc.